Mainz Biomed N.V. (NASDAQ: QUCY) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT MAINZ BIOMED N.V.

Mainz Biomed N.V. (NASDAQ: QUCY)
Listen to this Section

$2.02
-0.3100 ( -13.30% ) 985.5K

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples. The company operates in one operating segment, genetic diagnostic testing.

Market Data
Open $2.02
Previous Close $2.33
Volume 985.5K
Market Cap $56.01M
Day Range $1.96 - $2.35
52 Week Range $0.30 - $4.93
Shares Outstanding 22.77M
Change % -13.30%
Net Change ▼ -0.3100
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2021
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings

No data available for selected period.

Latest News

About US

Services

Stay Connected

× Before browsing our site, please accept our cookies policy